They evaluated receptors of WNT10B signaling and found that in AML, WNT10B signals through FZD4 and FZD5, whereas in T-ALL, WNT10B signals through FZD6 (Lazzaroni et al., 2016; Cassaro et al., 2021). Here, FZD6 is linked to acute myeloid leukemia.